Table 2. The expression of CDH4 and CDH1 in clinical and pathological characteristics of SACC.
Characteristics | For CDH4 | For CDH1 | |||||||
---|---|---|---|---|---|---|---|---|---|
Total | Low CDH4* | High CDH4* | P value | Total | Low CDH1 | High CDH1 | P value | ||
Gender | |||||||||
Female | 39 | 31 | 8 | 1.00 | 16 | 13 | 3 | 0.23 | |
Male | 28 | 22 | 6 | 14 | 8 | 6 | |||
Age | |||||||||
≤55 | 38 | 27 | 11 | 0.07 | 16 | 12 | 4 | 0.69 | |
>55 | 29 | 26 | 3 | 14 | 9 | 5 | |||
Stage | |||||||||
Early | 31 | 20 | 11 | 0.01** | 12 | 7 | 5 | 0.41 | |
Late | 36 | 33 | 3 | 18 | 14 | 4 | |||
Invasion | |||||||||
No | 28 | 21 | 7 | 0.55 | 11 | 7 | 4 | 0.69 | |
Yes | 39 | 32 | 7 | 19 | 14 | 5 | |||
Metastasis | |||||||||
(Lymph node and distant) | No | 51 | 38 | 13 | 0.16 | 25 | 17 | 8 | 1.00 |
Yes | 16 | 15 | 1 | 5 | 4 | 1 |